Partnerships

Our strategy and business development team seeks global and local collaboration opportunities with other industry players. These opportunities may include co-development, in-licensing and out-licensing arrangements. We have a proven track record of collaborating with hospital systems, biopharmaceutical and biotechnology companies across the globe which underscores our industry recognition and paves the way for long-term collaborations.

We are also seeking partnership opportunities to maximize the market potential of our products. We plan to identify lead partners by establishing a unique selection criteria, including primarily a commercialization team with a strong background in the biopharmaceutical industry, a proven track record of commercialization partnerships, and an endorsement of the vision and commitment of our pipeline products. We would like a mutually beneficial relationship whereby our partner can leverage our highly innovative culture and we can leverage our current and future business partners' knowledge, experience, and business networks to expand our market reach.

Canary is proud to partner with the Yaya Foundation as we join in the fight for children with 4H Leukodystrophy. We are committed to finding safe and effective treatments for this rare disease. We share the same dream that one day, every child with 4H Leukodystrophy will have the chance to live a long, healthy life.

We are leading our research portfolio with work on 4H Leukodystrophy using the latest technology. We will work closely with the Yaya foundation to accelerate the development of therapy options and cures. Yaya foundation’s deep knowledge of the disease, their network of scientists and clinicians, and their community of patients and families will be invaluable.

Know More Yaya Foundation

Canary is partnering with White Plains Hospital, a leading healthcare provider in New York, to advance the clinical development of our innovative technologies.

This collaboration will bring together our cutting-edge research and development expertise with White Plains Hospital’s renowned clinical acumen and patient-centric approach to healthcare. Through this partnership, we will work closely with world-renowned clinical leaders at White Plains Hospital to design and execute clinical trials that evaluate the safety and efficacy of our technologies in real-world settings. This collaboration will not only accelerate the clinical development of our technologies but also ensure that they are thoughtfully integrated into patient care to maximize their impact on patient outcomes.

Pioneering Gene Therapy and Precision Diagnostics

Our mission is to harness the transformative power of gene therapy and AI-driven precision diagnostics to revolutionize healthcare and empower individuals to live healthier, longer lives. We are pioneering a novel approach to vectorized gene therapy with the aim of providing a single-dose comprehensive and lasting solution to diseases and conditions that currently have few options.

Disclaimer:
Canary Global Inc.’s website includes future planned care offerings, that are currently in development and are subject to regulatory approval before they are able to be commercialized

Partnerships

Canary is partnering with White Plains Hospital, a leading healthcare provider in New York, to advance the clinical development of our innovative technologies.

Quick Links

Useful Links

Quick Contact

Follow Us